Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept as replacement therapy after ciclosporin cessation in moderate to severe plaque psoriasis
2006-004454-25Phase 4Completed
- Sponsor
- Wyeth
- Start
- Jan 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in plaque psoriasis comparing Etanercept arm with Placebo arm (2 arms). Primary endpoints: Change in PASI score, PASI AUC and 4 more. Started Jan 2007; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2006-004454-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004454-25.